Directors' Dealing

RNS Number : 2398M

Ergomed plc

04 January 2019

 

Ergomed Plc

("Ergomed" or the "Company")

Director's Dealing

Ergomed, a company focused on providing specialised services to the pharmaceutical industry, announces that on 24 December 2018, Dr Miroslav Reljanovic, founder and Executive Vice-Chairman of the Company, transferred 176,470 ordinary shares of 1 pence each in the Company ("Share(s)") to Andrew Mackie, a former Director of the Company (the "Transfer"). The Transfer took place following an exercise of options over Ergomed shares owned by Dr Miroslav Reljanovic which had been granted on 20 July 2015 at an exercise price of 1 pence per Share.

Following the Transfer, Dr Miroslav Reljanovic's holding has reduced to 10,955,767 Shares (representing 24.4 per cent. of the Company's issued share capital).

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Dr Miroslav Reljanovic
2	Reason for the notification
a)	Position/status	Founder and Executive Vice-Chairman
b)	Initial notification /Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Ergomed Plc
b)	Legal Entity Identifier	213800BVS8I9VMC1AP84
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of 1 pence each  GB00BN7ZCY67
b)	Nature of the transaction	Transfer of Shares
c)	Currency	GBP
d)	Price(s) and volume(s)	Price(s)	Volume(s)
		£0.01	176,470
e)	Aggregated information - Aggregated volume - Price - Aggregated total	Volume: 176,470 ordinary shares of 1 pence each, exercise price of 1 pence per share
f)	Date of the transaction	24 December 2018
g)	Place of the transaction	Outside of a trading venue

Enquiries:

Ergomed plc	Tel: [phone]
Stephen Stamp (Chief Executive Officer)
Numis Securities Limited	Tel: [phone]
Michael Meade / Freddie Barnfield (Nominated Adviser)
James Black (Broker)

 

END

 

 

DSHBIMMTMBJMBBL